Scott Dunseth Myers
Director · Zentalis Pharmaceuticals, Inc.
- 2024
- Jun 18, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott Dunseth Myers files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- WALTERS GROUP - $22.92M in ZNTL purchases and sales in the last 12 months
- David F. Novack - $1.78M in DVAX purchases and sales in the last 12 months
- Vincent Vultaggio - $105K in ZNTL purchases and sales in the last 12 months
- Julia Marie Eastland - $21K in ZNTL purchases and sales in the last 12 months
- Ingmar Bruns - $8K in ZNTL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Scott Dunseth Myers?
Scott Dunseth Myers is a corporate insider, tracked as Director of Zentalis Pharmaceuticals, Inc. (ZNTL). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Scott Dunseth Myers last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 5 filings going back to 2024.
Has Scott Dunseth Myers been buying or selling stock?
Recorded transactions: 1 open-market purchase ($41K) and 0 open-market sales across all tracked filings.
